3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
11
Obesity
4
Sarcopenia
3
Polycystic Ovary Syndrome
3
Neoplasms
3
Melanoma
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Malnutrition
2
Lymphoma, Follicular
2
Colorectal Neoplasms
2
Breast Carcinoma In Situ
2
Wound Infection
1
Weight Loss
1
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Psoriasis
1
Precancerous Conditions
1
Postoperative Complications
1
Polyps
1
Phagocyte Bactericidal Dysfunction
1
Pain
1
Paget's Disease, Mammary
1
Overweight
1
Osteoarthritis
1
Olfaction Disorders
1
Non-alcoholic Fatty Liver Disease
1
Interventions
Cholecalciferol
4
Nutrition Assessment
3
Exercise
3
Blood Pressure
3
Atorvastatin
3
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Vitamin E
2
Vitamin D
2
Rosuvastatin Calcium
2
Methods
2
Metformin
2
Gonadotropin-Releasing Hormone
2
Geritol
2
Fish Oils
2
Fatty Acids, Omega-3
2
Ethanol
2
Educational Status
2
Diet, Mediterranean
2
Aspirin
2
xinmailong
1
sofosbuvir-velpatasvir drug combination
1
pembrolizumab
1
palbociclib
1
ficlatuzumab
1
beta Carotene
1
amlodipine, atorvastatin drug combination
1
Vorinostat
1
Vitamin B 6
1
Vitamin B 12
1
Tumor Necrosis Factor Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cardiovascular Diseases
×
Docosahexaenoic Acids
×
Clear all
NCT04116203
2025-02-28
PCOS
University of Alberta
Phase 1
Completed
52 enrolled